What does CUSIP 14161WAB1 represent in this 13F holders report?

CUSIP 14161WAB1 is the security identifier for 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 used to aggregate holder disclosures.

How many institutions held 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in Q3 2025?

No institutional holders were reported for 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in Q3 2025; review adjacent reporting periods for trend context.

CARDLYTICS INC - NOTE 1.000% 9/1

CUSIP: 14161WAB1

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Debt / NOTE 1.000% 9/1
Total 13F principal: $0
Principal change: -$9,876,320
Total reported market value: $0
Number of holders: 0
Value change: -$31,163,712
Number of sells: 7

Quarterly Holders Quick Answers

What is CUSIP 14161WAB1?
CUSIP 14161WAB1 identifies 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2025

Recent filing periods for CUSIP 14161WAB1:

Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

CARDLYTICS INC - NOTE 1.000% 9/1

Q3 2025 13F Holders as of 30 Sep 2025

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q3 2025.